Intravascular large B-cell lymphoma

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Synonyms and keywords:

Overview

Classification

Intravascular large B-cell lymphoma may be classified into either

Intravascular large B-cell lymphoma classification
Name Description

Pathophysiology

Microscopic Pathology

Causes

There are no established causes for intravascular large B-cell lymphoma.

Differentiating type page name here from other Diseases

Intravascular large B-cell lymphoma must be differentiated from other diseases such as:


Epidemiology and Demographics

Age

The incidence of intravascular large B-cell lymphoma increases with age; the median age at diagnosis is 67 years.

Gender

Intravascular large B-cell lymphoma affects men and women equally.

Risk Factors

There are no established risk factors for intravascular large B-cell lymphoma.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for intravascular large B-cell lymphoma.[1]

Natural History, Complications and Prognosis

  • People with this type of lymphoma can also develop a very serious condition where certain parts of the immune system are activated (hemophagocytic syndrome).[2]
  • Hemophagocytic syndrome causes:


Diagnosis

Symptoms

Symptoms of the intravascular large B-cell lymphoma include:[2]

Physical Examination

Vitals

Skin

  • Skin rash

HEENT

Thorax

Abdomen

Extremities

Laboratory Findings

Laboratory tests for intravascular large B-cell lymphoma include:[2]

Biopsy

Lymph node biopsy is diagnostic of intravascular large B-cell lymphoma.

Other Imaging Findings

CT, MRI, and PET scan may be helpful in the diagnosis of intravascular large B-cell lymphoma.

Treatment

Medical Therapy

References

  1. Recommendations. U.S Preventive Services Task Force. Accessed on March 9, 2016
  2. 2.0 2.1 2.2 Intravascular large B-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf5ae3e27c3994bd54a7/. Accessed on March 09, 2016

Related Chapters



Template:WikiDoc Sources